264 related articles for article (PubMed ID: 30820936)
1. The proteostasis network provides targets for neurodegeneration.
Newton TM; Duce JA; Bayle ED
Br J Pharmacol; 2019 Sep; 176(18):3508-3514. PubMed ID: 30820936
[TBL] [Abstract][Full Text] [Related]
2. Molecular chaperones and neuronal proteostasis.
Smith HL; Li W; Cheetham ME
Semin Cell Dev Biol; 2015 Apr; 40():142-52. PubMed ID: 25770416
[TBL] [Abstract][Full Text] [Related]
3. Therapeutics for dementia and Alzheimer's disease: New directions for precision medicine.
Duce JA; Zhu X; Jacobson LH; Beart PM
Br J Pharmacol; 2019 Sep; 176(18):3409-3412. PubMed ID: 31468515
[TBL] [Abstract][Full Text] [Related]
4. Treating Alzheimer's disease by targeting iron.
Nikseresht S; Bush AI; Ayton S
Br J Pharmacol; 2019 Sep; 176(18):3622-3635. PubMed ID: 30632143
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of IL-17 rescues amyloid-β-induced neuroinflammation and memory impairment.
Cristiano C; Volpicelli F; Lippiello P; Buono B; Raucci F; Piccolo M; Iqbal AJ; Irace C; Miniaci MC; Perrone Capano C; Calignano A; Mascolo N; Maione F
Br J Pharmacol; 2019 Sep; 176(18):3544-3557. PubMed ID: 30673121
[TBL] [Abstract][Full Text] [Related]
6. Proteins and chemical chaperones involved in neuronal nicotinic receptor expression and function: an update.
Crespi A; Colombo SF; Gotti C
Br J Pharmacol; 2018 Jun; 175(11):1869-1879. PubMed ID: 28294298
[TBL] [Abstract][Full Text] [Related]
7. Don't forget astrocytes when targeting Alzheimer's disease.
Sadick JS; Liddelow SA
Br J Pharmacol; 2019 Sep; 176(18):3585-3598. PubMed ID: 30636042
[TBL] [Abstract][Full Text] [Related]
8. Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets.
Nizami S; Hall-Roberts H; Warrier S; Cowley SA; Di Daniel E
Br J Pharmacol; 2019 Sep; 176(18):3515-3532. PubMed ID: 30740661
[TBL] [Abstract][Full Text] [Related]
9. Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease.
Sinnige T; Yu A; Morimoto RI
Adv Exp Med Biol; 2020; 1243():53-68. PubMed ID: 32297211
[TBL] [Abstract][Full Text] [Related]
10. The involvement of microglia in Alzheimer's disease: a new dog in the fight.
Moore Z; Taylor JM; Crack PJ
Br J Pharmacol; 2019 Sep; 176(18):3533-3543. PubMed ID: 30445661
[TBL] [Abstract][Full Text] [Related]
11. Adeno-associated virus-based Alzheimer's disease mouse models and potential new therapeutic avenues.
Ittner LM; Klugmann M; Ke YD
Br J Pharmacol; 2019 Sep; 176(18):3649-3665. PubMed ID: 30817847
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms linking cerebrovascular dysfunction and tauopathy: Adding a layer of epiregulatory complexity.
Kim YA; Mellen M; Kizil C; Santa-Maria I
Br J Pharmacol; 2024 Mar; 181(6):879-895. PubMed ID: 37926507
[TBL] [Abstract][Full Text] [Related]
13. Xeroderma pigmentosum: overview of pharmacology and novel therapeutic strategies for neurological symptoms.
Abeti R; Zeitlberger A; Peelo C; Fassihi H; Sarkany RPE; Lehmann AR; Giunti P
Br J Pharmacol; 2019 Nov; 176(22):4293-4301. PubMed ID: 30499105
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities.
Perez Ortiz JM; Swerdlow RH
Br J Pharmacol; 2019 Sep; 176(18):3489-3507. PubMed ID: 30675901
[TBL] [Abstract][Full Text] [Related]
15. Chaperones in Neurodegeneration.
Lindberg I; Shorter J; Wiseman RL; Chiti F; Dickey CA; McLean PJ
J Neurosci; 2015 Oct; 35(41):13853-9. PubMed ID: 26468185
[TBL] [Abstract][Full Text] [Related]
16. A short perspective on the long road to effective treatments for Alzheimer's disease.
Reynolds DS
Br J Pharmacol; 2019 Sep; 176(18):3636-3648. PubMed ID: 30657599
[TBL] [Abstract][Full Text] [Related]
17. Amyloid precursor protein-mediated mitochondrial regulation and Alzheimer's disease.
Lopez Sanchez MIG; van Wijngaarden P; Trounce IA
Br J Pharmacol; 2019 Sep; 176(18):3464-3474. PubMed ID: 30471088
[TBL] [Abstract][Full Text] [Related]
18. Heat shock proteins and neuroprotection.
Trivedi S
Recent Pat DNA Gene Seq; 2007; 1(2):134-7. PubMed ID: 19075927
[TBL] [Abstract][Full Text] [Related]
19. The potential of memory enhancement through modulation of perineuronal nets.
Duncan JA; Foster R; Kwok JCF
Br J Pharmacol; 2019 Sep; 176(18):3611-3621. PubMed ID: 30924524
[TBL] [Abstract][Full Text] [Related]
20. Redox-based therapeutics in neurodegenerative disease.
McBean GJ; López MG; Wallner FK
Br J Pharmacol; 2017 Jun; 174(12):1750-1770. PubMed ID: 27477685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
